Evaluation by magnetic resonance imaging of aortic dilatation and coarctation in adult Turner syndrome patients

Clinical Endocrinology

Volumn 65, Issue 2, 2006, Pages 154-157

  Ilyas, Mohammad ^a   Chu, Carol ^b   Ettles, Duncan ^c   Mathew, Verghese ^c   Atkin, Stephen ^d,e  

^a Department of Endocrinology   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c HULL ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF HULL   (United Kingdom)

^e Michael White Diabetes Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; GROWTH HORMONE; HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MESALAZINE; PIZOTIFEN MALEATE; PREMPAK; RISEDRONIC ACID; THYROXINE;

ADULT; AORTA ANOMALY; AORTA COARCTATION; AORTA DILATATION; AORTA STENOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; GROWTH RETARDATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HORMONE SUBSTITUTION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT DEPARTMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIMARY AMENORRHEA; PRIORITY JOURNAL; SYMPTOMATOLOGY; THORACIC AORTA; TURNER SYNDROME;

ADULT; AORTA; AORTIC COARCTATION; AORTIC DISEASES; DILATATION, PATHOLOGIC; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; TURNER SYNDROME;

EID: 33746058337     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02557.x     Document Type: Article

References (7)

1. Saenger, P. (1993) Clinical Review 48: The current status of diagnosis and therapeutic intervention in Turner's syndrome. Journal of Clinical Endocrinology and Metabolism, 77, 297-301.
2. Frias, J.L. & Davenport, M.L. (2003) Health supervision for children with Turner syndrome. Pediatrics, 111, 692-702.
3. Landin-Wilhelmsen, K., Bryman, I. & Wilhelmsen, L. (2001) Cardiac malformations and hypertension, but no metabolic risk factors, are common in Turner syndrome. Journal of Clinical Endocrinology and Metabolism, 86, 4166-4170.
4. Elsheikh, M., Dunger, D.B., Conway, G.S. & Wass, J.A.H. (2002) Turner's syndrome in adulthood. Endocrine Reviews, 23, 120-140.
5. Lin, A.E., Lippe, B. & Rosenfeld, R.G. (1998) Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics, 102, e12. Available online at: http://pediatrics.aapublications.org/ cgi/reprint/102/1/e12 (last accessed 30.03.2006).
6. Saenger, P., Albertsson Wikland, K., Conway, G.S., Davenport, M., Graveholt, C.H., Hintz, R., Hovatta, O., Hultcrantz, M., Landin-Wilhemsen, K., Lin, A., Lippe, B., Pasquino, A.M., Ranke, M.B., Rosenfeld, R. & Silberbach, M. (2001) Recommendations for the diagnosis and management of Turner syndrome. Journal of Clinical Endocrinology and Metabolism, 86, 3061-3069.
7. Ostberg, J.E., Brookes, J.A.S., McCarthy, C., Halcox, J. & Conway, G.S. (2004) A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. Journal of Clinical Endocrinology and Metabolism, 89, 5966-5971.